-
Cypress Pharmaceutical
Distance: 0.4 Mi135 Industrial Blvd
39110 Madison -
Healthcare Financial Service Llc
Distance: 12.5 Mi643 Lakeland East Drive
39232 Jackson -
Rankin Ledger
Distance: 12.6 Mi2001 Airport Rd N Ste 207
39232-8846 Flowood -
Doctors Network Of America
Distance: 12.6 MiOffice Bldg 2001 Airport Rd N Ste 204
39232-8846 Flowood -
Kramer Homes Inc
Distance: 4.6 Mi18 Brookside Pl
39110-9767 Madison
Description
Strategic Promotion of ENTEX Formulations WraSer Pharmaceuticals, LLC to launch key ENTEX formulations. RIDGELAND, MS March 13, 2012 WraSer Pharmaceuticals, LLC (WraSer) a privately held Ridgeland, Mississippi based pharmaceutical company, is pleased to announce the development and launch of the successful brand, ENTEX to reinforce its commitment to otolaryngologists, (ear, nose and throat doctors). WraSer Pharmaceuticals will target key otolaryngologists and primary care medical practitioners to increase the market for ENTEX oral tablets and liquid, the expectorant containing medications (Guaifenesin, USP) makes phlegm easier to cough up; Guaifenesin is also the only approved expectorant on the market, which is supposed to help loosen lung secretions and make them easier to cough up. Key formulations are currently available nationally through healthcare provider prescriptions, wholesale & pharmacy distribution, and available online at www.wraser.com. We are very excited to reintroduce the well known brand ENTEX, to the otolaryngologist and primary care providers we serve, said Ford Mundy, Vice President of Brands for WraSer Pharmaceuticals.
Based in Ridgeland, Mississippi, privately held WraSer Pharmaceuticals is an emerging pharmaceutical company that identifies, develops, and markets proprietary pharmaceutical products to physicians and pharmacies throughout the United States. WraSer’s professional, results-oriented staff, combined with our strategic business alliances and innovative sales model have established WraSer as a pace setter in its market category. Founded in 2002, WraSer Pharmaceuticals is committed to bringing proprietary products to market each year and expanding it sales force annually. WraSer will continue to leverage its collective Otic Infections, Upper and Lower Respiratory, and Pain Management expertise to keep developing a portfolio of innovative, therapeutically safe and cost effective products.
WraSer Pharmaceuticals has assembled a strong management and sales team who have experience in a variety of small, mid-level, and large pharmaceutical companies, as well as other Fortune 500 corporate entities. This experience coupled with entrepreneurial spirit and the drive to succeed has been the building blocks for WraSer Pharmaceuticals.
WraSer is a privately held specialty pharmaceutical company headquartered in Ridgeland, MS. The Company actively markets prescription pharmaceutical products focused on primary care, pediatric, pain management, and dermatological markets. WraSer markets its products through its proprietary sales force. The Company is continually expanding its product portfolio through direct development and FDA submissions, partnerships and in-licensing agreements.